Aerie Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2022 | Q3 2022 | -$0.56 | $36.13 M | |||
| 08/04/2022 | Q2 2022 | -$0.41 | $33.31 M | |||
| 05/05/2022 | Q1 2022 | -$0.76 | $29.84 M | |||
| 02/24/2022 | Q4 2021 | $0.98 | $114.67 M | |||
| 11/04/2021 | Q3 2021 | -$0.86 | $29.31 M | |||
| 08/04/2021 | Q2 2021 | -$0.84 | $27.19 M | |||
| 05/05/2021 | Q1 2021 | -$0.91 | $22.97 M | |||
| 02/25/2021 | Q4 2020 | -$1.00 | $24.68 M | |||
| 11/05/2020 | Q3 2020 | -$0.86 | $20.08 M | |||
| 08/06/2020 | Q2 2020 | -$1.05 | $18.03 M | |||
| 05/07/2020 | Q1 2020 | -$1.07 | $20.34 M | |||
| 02/24/2020 | Q4 2019 | -$1.21 | $24.66 M | |||
| 11/06/2019 | Q3 2019 | -$1.09 | $18.54 M | |||
| 08/07/2019 | Q2 2019 | -$1.04 | $15.84 M | |||
| 05/07/2019 | Q1 2019 | -$1.06 | $10.85 M | |||
| 03/01/2019 | Q4 2018 | -$1.14 | $14.46 M | |||
| 11/07/2018 | Q3 2018 | -$1.96 | $7.30 M | |||
| 08/08/2018 | Q2 2018 | -$1.40 | $2.42 M | |||
| 05/08/2018 | Q1 2018 | -$1.05 | $0 | |||
| 03/01/2018 | Q4 2017 | -$1.60 | $0 |
Aerie Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
Did Aerie Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Aerie Pharmaceuticals, Inc. (:AERI) reported $-0.27 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.44 by $0.17.
-
How can I listen to Aerie Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Aerie Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Aerie Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Aerie Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Aerie Pharmaceuticals, Inc. generate each year?
Aerie Pharmaceuticals, Inc. (:AERI) has a recorded annual revenue of $194.13 M.
-
How much profit does Aerie Pharmaceuticals, Inc. generate each year?
Aerie Pharmaceuticals, Inc. (:AERI) has a recorded net income of $194.13 M. Aerie Pharmaceuticals, Inc. has generated $-1.61 earnings per share over the last four quarters.
-
What is Aerie Pharmaceuticals, Inc.'s price-to-earnings ratio?
Aerie Pharmaceuticals, Inc. (:AERI) has a price-to-earnings ratio of -9.45 and price/earnings-to-growth ratio is -0.09.
